{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:30:06Z","timestamp":1787862606935,"version":"build-2784847793"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Mochida Pharmaceutical Co., Ltd."}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.pbb.2016.02.005","type":"journal-article","created":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T13:57:10Z","timestamp":1455631030000},"page":"7-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Effects of escitalopram, R-citalopram, and reboxetine on serum levels of tumor necrosis factor-\u03b1, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration"],"prefix":"10.1016","volume":"144","author":[{"given":"Chao","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-chun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.pbb.2016.02.005_bb0005","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1177\/0269881110364271","article-title":"Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test","volume":"25","author":"Andreasen","year":"2011","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2016.02.005_bb0010","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbr.2008.08.016","article-title":"Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests","volume":"197","author":"Andreasen","year":"2009","journal-title":"Behav. Brain Res."},{"issue":"9","key":"10.1016\/j.pbb.2016.02.005_bb0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd1825","article-title":"The ascent of mouse: advances in modeling human depression and anxiety","volume":"4","author":"Cryan","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.pbb.2016.02.005_bb0020","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nature Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.pbb.2016.02.005_bb0025","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"4\u20135","key":"10.1016\/j.pbb.2016.02.005_bb0030","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neubiorev.2005.03.023","article-title":"Cytokines as mediators of depression: what can we learn from animal studies?","volume":"29","author":"Dunn","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.pbb.2016.02.005_bb0035","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1124\/jpet.103.058206","article-title":"Anxiolytic-like effects of escitalopram, citalopram, and R-citalopram in maternally separated mouse pups","volume":"308","author":"Fish","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.02.005_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.10.002","article-title":"Integrating the monoamine, neurotrophin and cytokine hypotheses of depression\u2013a central role for the serotonin transporter?","volume":"147","author":"Haase","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.pbb.2016.02.005_bb0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.brainresrev.2009.05.005","article-title":"Emerging role of glutamate in the pathophysiology of major depressive disorder","volume":"61","author":"Hashimoto","year":"2009","journal-title":"Brain Res. Rev."},{"issue":"4","key":"10.1016\/j.pbb.2016.02.005_bb0050","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.3390\/ijms16047796","article-title":"Inflammatory biomarkers as differential predictors of antidepressant response","volume":"16","author":"Hashimoto","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.pbb.2016.02.005_bb0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF01244820","article-title":"The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer","volume":"88","author":"Hyttel","year":"1992","journal-title":"J. Neural Transm. Gen. Sect."},{"key":"10.1016\/j.pbb.2016.02.005_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2013.10.026","article-title":"Effects of perillaldehyde on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration","volume":"116","author":"Ji","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.pbb.2016.02.005_bb0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.9758\/cpn.2014.12.1.31","article-title":"Effects of brilliant blue G on serum tumor necrosis factor-\u03b1 levels and depression-like behavior in mice after lipopolysaccharide administration","volume":"12","author":"Ma","year":"2014","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"4","key":"10.1016\/j.pbb.2016.02.005_bb0070","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbi.2010.02.005","article-title":"Noradrenaline acting at central \u03b2-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: implications for neurodegeneration","volume":"24","author":"McNamee","year":"2010","journal-title":"Brain Behav. Immun."},{"issue":"9","key":"10.1016\/j.pbb.2016.02.005_bb0075","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.pbb.2016.02.005_bb0080","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice","volume":"14","author":"O'Connor","year":"2009","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pbb.2016.02.005_bb0085","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.pbb.2012.12.003","article-title":"Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration","volume":"103","author":"Ohgi","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.pbb.2016.02.005_bb0090","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0006-3223(01)01145-3","article-title":"Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine","volume":"50","author":"Owens","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.pbb.2016.02.005_bb0095","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1001\/archgenpsychiatry.2010.161","article-title":"Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression","volume":"67","author":"Raison","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pbb.2016.02.005_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.157","article-title":"BDNF-TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms","volume":"5","author":"Ren","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.pbb.2016.02.005_bb0105","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.pbb.2003.12.001","article-title":"R-citalopram inhibits functional and 5-HTP-evoked behavioural responses to the SSRI, escitalopram","volume":"77","author":"S\u00e1nchez","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.pbb.2016.02.005_bb0110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pnpbp.2004.11.003","article-title":"Cytokines and major depression","volume":"29","author":"Schiepers","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.pbb.2016.02.005_bb0115","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/mp.2010.52","article-title":"Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression","volume":"16","author":"Shelton","year":"2011","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2016.02.005_bb0120","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/sj.bjp.0705738","article-title":"R-citalopram functionally antagonises escitalopram in vivo and in vitro: evidence for kinetic interaction at the serotonin transporter","volume":"142","author":"St\u00f3rustovu","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2016.02.005_bb0125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR\u204eD: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.pbb.2016.02.005_bb0130","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0006-3223(99)00291-7","article-title":"Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor","volume":"47","author":"Wong","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2016.02.005_bb0135","unstructured":"World Health Organization (WHO) Depression. Fact sheet No. 369\/October 2012. Available at http:\/\/www.who.int\/mediacentre\/factsheets\/fs369\/en\/index.html."},{"key":"10.1016\/j.pbb.2016.02.005_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-acting and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pbb.2016.02.005_bb0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pbb.2015.06.012","article-title":"Effects of amycenone on serum levels of tumor necrosis factor-\u03b1, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration","volume":"136","author":"Yao","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.pbb.2016.02.005_bb0150","doi-asserted-by":"crossref","first-page":"pyu077","DOI":"10.1093\/ijnp\/pyu077","article-title":"Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation","volume":"18","author":"Zhang","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2016.02.005_bb0155","article-title":"Brain-derived neurotrophic factor (BDNF) \u2013 TrkB signaling in inflammation-related depression and potential therapeutic targets","volume":"18","author":"Zhang","year":"2016","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2016.02.005_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-011-2463-5","article-title":"Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter\u2013a review of current understanding of its mechanism of action","volume":"219","author":"Zhong","year":"2012","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pbb.2016.02.005_bb0165","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neulet.2009.07.030","article-title":"An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: kinetic binding studies with the ALI\/VFL\u2013SI\/TT mutant","volume":"462","author":"Zhong","year":"2009","journal-title":"Neurosci. Lett."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305716300181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305716300181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T06:27:45Z","timestamp":1536992865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305716300181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":33,"alternative-id":["S0091305716300181"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2016.02.005","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of escitalopram, R-citalopram, and reboxetine on serum levels of tumor necrosis factor-\u03b1, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2016.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}